Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: Findings of the PERSPECTIVES study

British Journal of Ophthalmology

Volumn 96, Issue 10, 2012, Pages 1351-1354

  Chakravarthy, Usha ^a   Staurenghi, Giovanni ^b   Kwok, Kenneth ^c   Tressler, Charles S ^c   Buggage, Ronald ^d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c PFIZER INC   (United States)

^d Novagali Pharma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEGAPTANIB;

ADULT; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; LETTER; MAJOR CLINICAL STUDY; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; OPEN STUDY; PRIORITY JOURNAL; READING SPEED; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ANGIOGENESIS INHIBITORS; APTAMERS, NUCLEOTIDE; CHOROIDAL NEOVASCULARIZATION; EARLY DIAGNOSIS; HUMANS; MACULAR DEGENERATION; MIDDLE AGED;

EID: 84867074193     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301444     Document Type: Letter

References (6)

1. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44. (Pubitemid 44511558)
2. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16. (Pubitemid 40051904)
3. Sivaprasad S, Hykin P, Saeed A, et al. Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience. Eye (Lond) 2010;24:793-8.
4. Lafaut BA, Bartz-Schmidt KU, Vanden Broecke C, et al. Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol 2000;84:239-43. (Pubitemid 30251676)
5. Gonzales CR. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina 2005;25:815-27. (Pubitemid 41456570)
6. McClure ME, Hart PM, Jackson AJ, et al. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol 2000;84:244-50. (Pubitemid 30251677)